Blog
RSS FeedPosted by Michael Wonder on 22 Dec 2016
EMA publishes EPAR for Venclyxto
22 December 2016 - The EMA has published an EPAR for AbbVie's new BCL inhibitor. ...
Posted by Michael Wonder on 07 Dec 2016
EMA publishes EPAR for Ninlaro
7 December 2016 - The EMA has published a EPAR for Takeda's proteasome inhibitor. ...
Posted by Michael Wonder on 29 Nov 2016
TGA business plan 2016-17
29 November 2016 - The TGA Business Plan 2016-17 provides an overview of our strategic considerations including: ...
Posted by Michael Wonder on 29 Nov 2016
TGA publishes AusPAR for Spiriva Respimat
29 November 2015 - AusPAR published 18 months after registration. ...
Posted by Michael Wonder on 25 Nov 2016
EMA publishes EPAR for Ibrance
25 November 2016 - The EMA has published an EPAR for Pfizer's new cyclin-dependent kinase (CDK4/6) inhibitor. ...
Posted by Michael Wonder on 23 Nov 2016
EMA publishes EPAR for Lartruvo
23 November 2016 - The EMA has published a EPAR for Eli Lilly's platelet derived growth factor receptor antagonist. ...
Posted by Michael Wonder on 02 Nov 2016
TGA publishes AusPAR for Esmya
2 November 2016 - The TGA has published an AusPAR for Vifor Pharma's Esmya. ...
Posted by Michael Wonder on 18 Oct 2016
TGA publishes AusPAR for Keytruda
18 October 2016 - The TGA has finally published an AusPAR for MSD's PD-1 inhibitor. ...
Posted by Michael Wonder on 14 Oct 2016
TGA publishes AusPAR for Actemra
14 October 2016 - The TGA has published an AusPAR for the new formulation of Roche's Actemra (tocilizumab). ...
Posted by Michael Wonder on 14 Oct 2016
TGA publishes AusPAR for Zurampic
14 October 2016 - The TGA has published an AusPAR for AstraZeneca's Zurampic. ...
Posted by Michael Wonder on 14 Oct 2016
TGA publishes AusPAR for Entresto
14 October 2016 - The TGA has published an AusPAR for Novartis' Entresto. ...
Posted by Michael Wonder on 13 Oct 2016
FY 2016 generic approvals by FDA: a new record under GDUFA
12 October 2016 - The US FDA published final Fiscal Year 2016 abbreviated new drug application (ANDA) approvals earlier this ...
Posted by Michael Wonder on 12 Oct 2016
EMA publishes EPAR for Cabometyx (cabozantinib maleate)
12 October 2016 - The EMA has published an EPAR for Ipsen's Cabometyx. ...
Posted by Michael Wonder on 11 Oct 2016
ICER releases corrected evidence report on treatments for non-small-cell lung cancer
7 October 2016 - PD-1 value-based price benchmarks are updated while the main conclusions of the analysis remain unchanged. ...
Posted by Michael Wonder on 09 Oct 2016
Human medicines highlights - September 2016
7 October 2016 - Key information for patients, consumers and healthcare professionals published monthly by the EMA. ...